Neurogene (NGNE) Other Non-Current Assets (2013 - 2026)

Neurogene (NGNE) posted Other Non-Current Assets of $1.1 million for Q1 2026, up 217.99% on a QoQ basis from $339000.0 in Q4 2025, and up 20.31% year-over-year from $896000.0 in Q1 2025.

Neurogene (NGNE) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Neurogene's Other Non-Current Assets history runs 11 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 20.31% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 20.31% YoY) and the FY2025 annual result came in at $339000.0, down 65.23% from the prior year.
  • Other Non-Current Assets was $1.1 million for Q1 2026 at Neurogene, up from $339000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.0 million in Q2 2022 and bottomed at $300000.0 in Q2 2024.
  • A 5-year average of $917375.0 and a median of $842500.0 in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets sank 73.81% — and 2025, when it jumped 164.31%.
  • Neurogene's Other Non-Current Assets stood at $1.9 million in 2022, then sank by 60.04% to $764000.0 in 2023, then grew by 27.62% to $975000.0 in 2024, then tumbled by 65.23% to $339000.0 in 2025, then jumped by 217.99% to $1.1 million in 2026.
  • Business Quant data shows NGNE's Other Non-Current Assets at $1.1 million in Q1 2026, $339000.0 in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Neurogene 17.50 Mn 17.50 Mn - 1.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Mn
Dec 31, 2025 339,000.00
Sep 30, 2025 1.06 Mn
Jun 30, 2025 300,000.00
Mar 31, 2025 896,000.00
Dec 31, 2024 975,000.00
Sep 30, 2024 789,000.00
Jun 30, 2024 300,000.00
Mar 31, 2024 339,000.00
Dec 31, 2023 764,000.00
Sep 30, 2023 524,000.00
Jun 30, 2023 529,000.00
Mar 31, 2023 905,000.00
Sep 30, 2022 1.91 Mn
Jun 30, 2022 2.02 Mn
Mar 31, 2022 1.95 Mn
Dec 31, 2021 1.93 Mn
Sep 30, 2021 1.99 Mn
Jun 30, 2021 1.93 Mn
Mar 31, 2021 1.92 Mn